---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-028035"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2022-10-11T23:59:59+00:00"
generated_at: "2026-06-23T04:16:00.619065+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nephros sells Pathogen Detection Systems business, reports prelim Q3 revenue ~$2.5M

## Summary
- Entered definitive agreement to sell Pathogen Detection Systems (PDS) business to BWSI; expected close mid-November 2022.
- Sale includes seven-year earn-out based on a portion of gross profits from PDS products.
- Preliminary Q3 2022 revenue expected ~$2.5M; Active Customer Sites up 18% YoY to 1,391.
- Cash position ~$3.9M at quarter end; sale expected to reduce expenses by ~$350k per quarter.
- Company aims for positive net cash flow by mid-2023.

## SEC filing metadata
- accession: 0001493152-22-028035
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2022-10-11T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000149315222028035/0001493152-22-028035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000149315222028035/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-028035
- JSON: https://secwatch.observer/filing/0001493152-22-028035.json
- Plain text: https://secwatch.observer/filing/0001493152-22-028035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.